Chapter: 1 INTRODUCTION

1.1. REPORT DESCRIPTION
1.2. KEY BENEFITS
1.3. KEY MARKET SEGMENTS
1.4. RESEARCH METHODOLOGY

1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools & models

Chapter: 2 EXECUTIVE SUMMARY

2.1. CXO PERSPECTIVE

Chapter: 3 MARKET OVERVIEW

3.1. MARKET DEFINITION AND SCOPE
3.2. KEY FINDINGS

3.2.1. Top investment pockets
3.2.2. Top winning strategies

3.3. MARKET SHARE ANALYSIS, 2016
3.4. PORTER’S FIVE FORCES ANALYSIS
3.5. MARKET DYNAMICS

3.5.1. Drivers
3.5.2. Restraints
3.5.3. Opportunities

Chapter: 4 PHARMACEUTICAL GLYCERINE MARKET, BY APPLICATION 

4.1. OVERVIEW

4.1.1. Market size and forecast

4.2. EXCIPIENT

4.2.1. Key market trends
4.2.2. Growth factors and opportunities
4.2.3. Market size and forecast
4.2.4. Fillers & Plasticizer

4.2.4.1. Market size and forecast

4.2.5. Solubilizer & Emulsifier

4.2.5.1. Market size and forecast

4.2.6. Solvent

4.2.6.1. Market size and forecast

4.2.7. Coatings

4.2.7.1. Market size and forecast

4.2.8. Diluent & Base

4.2.8.1. Market size and forecast

4.2.9. Lubricant

4.2.9.1. Market size and forecast

4.2.10. Thickener

4.2.10.1. Market size and forecast

4.2.11. Sweetener

4.2.11.1. Market size and forecast

4.2.12. Others

4.2.12.1. Market size and forecast

4.3. DRUG

4.3.1. Key market trends
4.3.2. Growth factors and opportunities
4.3.3. Market size and forecast
4.3.4. Skin Care

4.3.4.1. Market size and forecast

4.3.5. Ophthalmic

4.3.5.1. Market size and forecast

4.3.6. Osmotic Diuretic

4.3.6.1. Market size and forecast

4.3.7. Others

4.3.7.1. Market size and forecast

Chapter: 5 PHARMACEUTICAL GLYCERINE MARKET, BY ROUTE OF ADMINISTRATION

5.1. OVERVIEW

5.1.1. Market size and forecast

5.2. ORAL

5.2.1. Market size and forecast

5.3. RECTAL

5.3.1. Market size and forecast

5.4. INTRAVENOUS

5.4.1. Market size and forecast

5.5. OPHTHALMIC

5.5.1. Market size and forecast

5.6. TOPICAL

5.6.1. Market size and forecast

Chapter: 6 PHARMACEUTICAL GLYCERINE MARKET, BY REGION

6.1. OVERVIEW
6.2. NORTH AMERICA

6.2.1. Key market trends
6.2.2. Key growth factors and opportunities
6.2.3. Market size and forecast

6.2.3.1. U.S. market size and forecast
6.2.3.2. Canada market size and forecast
6.2.3.3. Mexico market size and forecast

6.2.4. North America Pharmaceutical Glycerine Market by Application
6.2.5. North America Pharmaceutical Glycerine Market by Route of Administration

6.3. EUROPE

6.3.1. Key market trends
6.3.2. Key growth factors and opportunities
6.3.3. Market size and forecast

6.3.3.1. Germany market size and forecast
6.3.3.2. France market size and forecast
6.3.3.3. UK market size and forecast
6.3.3.4. Italy market size and forecast
6.3.3.5. Spain market size and forecast
6.3.3.6. Rest of Europe market size and forecast

6.3.4. Europe Pharmaceutical Glycerine Market by Application
6.3.5. Europe Pharmaceutical Glycerine Market by Route of Administration

6.4. ASIA-PACIFIC

6.4.1. Key market trends
6.4.2. Key growth factors and opportunities
6.4.3. Market size and forecast

6.4.3.1. Japan market size and forecast
6.4.3.2. China market size and forecast
6.4.3.3. India market size and forecast
6.4.3.4. Rest of Asia-Pacific market size and forecast

6.4.4. Asia-Pacific Pharmaceutical Glycerine Market by Application
6.4.5. Asia-Pacific Pharmaceutical Glycerine Market by Route of Administration

6.5. LAMEA

6.5.1. Key market trends
6.5.2. Key growth factors and opportunities
6.5.3. Market size and forecast

6.5.3.1. Latin America market size and forecast
6.5.3.2. Middle East market size and forecast
6.5.3.3. Africa market size and forecast

6.5.4. LAMEA Pharmaceutical Glycerine Market by Application
6.5.5. LAMEA Pharmaceutical Glycerine Market by Route of Administration

Chapter: 7 COMPANY PROFILES

7.1. AEMETIS, INC.

7.1.1. Operating business segments
7.1.2. Business performance
7.1.3. Key strategic moves and developments

7.2. ARCHER DANIELS MIDLAND COMPANY

7.2.1. Operating business segments
7.2.2. Business performance
7.2.3. Key strategic moves and developments

7.3. CRODA INTERNATIONAL PLC

7.3.1. Operating business segments
7.3.2. Business performance
7.3.3. Key strategic moves and developments

7.4. EMERY OLEOCHEMICALS GROUP

7.4.1. Operating business segments
7.4.2. Business performance
7.4.3. Key strategic moves and developments

7.5. GODREJ GROUP

7.5.1. Operating business segments
7.5.2. Business performance
7.5.3. Key strategic moves and developments

7.6. KAO CORPORATION

7.6.1. Operating business segments
7.6.2. Business performance
7.6.3. Key strategic moves and developments

7.7. KUALA LUMPUR KEPONG BERHAD

7.7.1. Operating business segments
7.7.2. Business performance
7.7.3. Key strategic moves and developments

7.8. PROCTER & GAMBLE CO.

7.8.1. Operating business segments
7.8.2. Business performance
7.8.3. Key strategic moves and developments

7.9. SAKAMOTO YAKUHIN KOGYO CO., LTD

7.9.1. Operating business segments
7.9.2. Business performance
7.9.3. Key strategic moves and developments

7.10. THE DOW CHEMICAL COMPANY

7.10.1. Operating business segments
7.10.2. Business performance
7.10.3. Key strategic moves and developments